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A B ST R AC T  
 
Aim: To investigate the possible effects of polymorphisms in genes encoding some important 
antioxidant enzymes such as super oxide dismutase 2 (SOD2), glutathione peroxidase 1 (GPX1), 
endothelial NOS (eNOS) and catalase (CAT) in patients with polycystic ovary syndrome (PCOS). 
Methods: Peripheral blood of 100 patients with PCOS and 100 healthy control group were collected, 
Polymorphisms in related genes was investigated by using polymerase chain reaction-restriction 
fragment length polymorphism. In addition, the related biochemical values of the patients were also 
investigated. 
Result: In our study there is no significant results for SOD2 gene but the results obtained between 
GPX1, eNOS and CAT genes were significant. Fasting blood sugar (FBS), insulin, triglyceride, waist 
circumference and dehydroepiandrosterone sulphate (DHEAS) were found to be significant with the 
disease, whereas follicle-stimulating hormone (FSH) was found to be effective in preventing the 
disease. 
Conclusions: These findings suggest that polymorphisms in genes encoding GPX1, eNOS and CAT 
enzymes may be associated with PCOS. Additionally, it is thought that the genes of FBS, triglyceride, 
insulin, DHEAS and waist circumference are important in the pathogenesis of the disease in the 
presence of homozygous mutation. 
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Introduction 
Polycystic over syndrome (PCOS); is a 
complex, chronic, metabolic disease 
characterized by anovulation and 
hyperandrogenism, affecting approximately 5-
10% of women in the reproductive period [1]. 
Chronic uncommitted estrogen effects in 
patients with PCOS are features that may 
increase chronic anovulation, obesity, 
hyperinsulinemia, endometrial hyperplasia and 
adenocarcinoma risk. Anovulation causes 
endometrium to be exposed to mitogenic 
effects of estrogen, and this effect, which 
cannot be met by progesterone, is continuous, 
resulting in atypical or atypical endometrial 
hyperplasia and increased cancer incidence 
[2]. Estrogen and its metabolites play a role in 
tumor development with direct damage to 
DNA [3]. At the same time estrogen and its 
metabolites enter the redox cycle and form 
oxygen radicals, which cause oxidative stress, 
lipid peroxidation [4] and cause DNA damage. 
[3-5]. 
Polymorphisms in genes encoding antioxidant 
enzymes cause various diseases [6]. Oxidant 
and antioxidant systems, which are important 
in the physiological process in organism, have 
many roles on female reproductivities. 
Infertility etiopathogenesis plays an important 
role in oxidative stress in women. Oxidative 
stress has been shown to play a role in the 
development of reproductive diseases such as 
polycystic over syndrome, endometriosis and 
unexplained infertility [7]. Nitric oxide (NO) is 
a mediator role in reproductive events; NO is 
one of the many intraovarian agents involved 
in the ovary. NO plays a role in the fulfillment 
of blood-follicular barrier function by 
gonadotropins. NO as an antioxidant, may play 
a role in pubertal maturation, ovulation 
capacity, early embryological development, 
gestational continuation, and menopause 
timing, as well as relaxation in vascular 
smooth muscles, as compared to preliminary 
studies in humans, and also NO has 
vasodilation effect [8,9]. Because of all the 
functions of NO which mentioned above, we 
think that endothelial NOS (eNOS) 
polymorphism may be related to PCOS. 
Another antioxidant is glutathione peroxidase 
1 (GPX1) gene that is expressed in prostate, 
breast and reproductive tracts cells and 
protects them against oxidative damage. Low 
GPX1 activity increases oxidative stress and 
increases susceptibility to various diseases and 
cancers [10]. GPX1 is a selenium-dependent 
cytosolic antioxidant and GPX1gene family 
has important roles in electron transport and 
free radical steps [11]. Superoxide dismutase 2 
(SOD2) directly converts superoxide radicals 
to hydrogen peroxide and molecular oxygen. It 
has been shown that polymorphism-inducing 
genes encoding SOD enzyme are predisposed 
to Behçet, diabetes and various types of cancer 
[12]. Catalase; in the glycoprotein structure, it 
is a hemoprotein composed of four subunits 
and mainly found in the cytoplasm and 
endoplasmic reticulum of the cell. Particularly 
when the amount of H2O2 is excessively 
increased, it enters the circuit and turns this 
molecule into water with a great specificity 
[13,14]. We investigated the effectiveness of 
the polymorphisms of genes encoding 
antioxidant enzymes such as SOD2, GPX1, 
eNOS, and catalase (CAT) in the 
etiopathogenesis of PCOS. 
 
Methods 
The patient group of our study was composed 
of 100 female patients aged 15-39 years who 
applied to Bolu Abant Izzet Baysal University 
Medical Faculty Obstetrics and Gynecology 
Department and clinically diagnosed as PCOS. 
Ethics committee approval for the study was 
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obtained from Istanbul University Clinical 
Research Ethics Committee (/2015/104). All 
procedures performed in studies involving 
human participants were in accordance with 
the ethical standards of the institutional and/or 
national research committee and with the 1964 
Helsinki declaration and its later amendments 
or comparable ethical standards.  This article 
does not contain any studies with animals 
performed by any of the authors. Demographic 
characteristics of patients are shown in Table 
1. Informed consent was obtained from all 
individual participants included in the study. 
Informed consent forms were obtained from 
parents for individuals younger than 16 years 
of age. When the control group was 
established, care was taken to ensure that there 
was no evidence of clinical or biochemical 
hyperandrogenism with a regular mens cycle, 
and that they did not have diagnostic criteria 
for PCOS. Peripheral venous blood of the 
subjects included in the study were taken with 
the tubes with ethylenediaminetetraacetic acid 
(EDTA). Subsequently, genomic DNAs were 
isolated at molecular genetics laboratory of our 
department using appropriate isolation kit. 
Polymerase chain reactions (PCRs) were 
performed under the appropriate conditions 
using the isolated DNAs, and primers designed 
for the gene regions. The PCR, restriction 
enzyme digestion, and electrophoresis 
procedures of the study were carried out at 
Istanbul University, Aziz Sancar Experimental 
Medical Research Institute, Molecular 
Medicine Department. In addition, fasting 
blood sugar (FBS), insulin, thyroid stimulating 
hormone (TSH) free triiodothyronine (free 
T3), free thyroxine (free T4), triglyceride 
(TG), high density lipoprotein (HDL),  low 
density lipoprotein (LDL), very-low-density 
lipoprotein (VLDL), luteinizing hormone 
(LH), estradiol 2 (E2), prolactin hormone, 
progesterone, testosterone, 
dehydroepiandrosterone sulphate (DHEAS), 
follicle-stimulating hormone (FSH) and waist 
circumference were evaluated. Analysis of the 
biochemical data of the study group was made 
by Department of Medical Biochemistry, Bolu 
Abant Izzet Baysal University Medical faculty. 
Statistical analysis 
Statistical analysis of the data was performed 
using the SPSS 17.0 package program. Chi-
square test was used to compare categorical 
variables. In comparison of continuous 
variables between groups, it was determined 
whether they were parametric or non-
parametric by Shapiro Wilk test. Student's t 
test was then performed for parametric 
subjects and Mann Whitney U test for non-
parametric subjects. The analysis of 
dependent and independent variables was 
performed by Binary Logistic Regression 
analysis. Assessment of risk factors for all 
genotypes and alleles belonging to the gene 
was performed using the Kruskall Wallis test, 
provided that the groups were within the 
group. 
 
Results 
Significant results were found for the weight 
and waist circumference of patients and 
control groups (p <0,001 and p <0,001). There 
was no significant difference between the 
groups in terms of age and height (p = 0,085 
and p = 0,243) (Table 1). In terms of 
biochemical parameters, TG (p <0,001), 
VLDL (p <0,001), free T3 (p=0,027), FSH 
(p<0,001), DHEAS (p=0,006), testosterone 
(p<0,001), fasting blood sugar (p=0,027), 
insulin (p=0,001). Statistically significant 
difference was observed in terms of values that 
are given in Table 2. As a result of analysis of 
the polymorphisms in the genes, 
polymorphisms in GPX1 (p = 0,002), eNOS (p 
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= 0,001), CAT (p = 0,031) genes were found 
to be significant among the groups. 
Polymorphism in the SOD2 gene was not 
found to be statistically significant between the 
groups (Table 3). 
 
Tablo 1. Evaluation of demographic properties 
of the groups. 
 
 
 
 
 
 
 
 
Tablo 2. Evaluation of the biochemical 
parameters of the groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. The genotype and allele distributions 
of genes in the patient and the control group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
When the genotypes and alleles of the genes 
were evaluated, SOD2 (TT), GPX11 (TT) and 
eNOS (TT) homozygous mutation genotypes 
were statistically significant between the 
groups (p = 0,024 and p = 0003) while CAT 
(TT) showed no significant difference between 
the groups for homozygous genotypes (p = 
0,262 and p = 0,535). In addition, GPX1 (TT) 
and eNOS (TT) genotypes alone and in 
patients and controls were evaluated with other 
risk factors. Assessment of PCOS risk factors 
in the presence of the homozygous mutation 
genotype (TT) of GPX1 gene is given in Table 
4. The genotype of homozygous mutation in 
GPX1 gene was found to be significant among 
the groups. However, GPX1 homozygote 
mutation was also found to be significant when 
compared to PCOS risk factors. In addition, 
GPX1 homozygote mutation genotype, TG, 
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FSH and DHEAS were found to be significant 
in PCOS (p=0,001, p = 0,005 and p = 0,026). 
Significant results were obtained when the 
presence of the eNOS homozygous mutation 
genotype and the risk factors of PCOS were 
evaluated together. TG, FSH and DHEAS 
were statistically significant in the presence of 
the eNOS homozygous mutation genotype (p 
<0,001, p = 0,014 and p = 0,005). 
 
Table 4: Evaluation of PCOS risk factors in 
the presence of GPX1 homozygous mutation 
genotype. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The evaluation of heterozygous genotypes in 
the genes by PCOS risk factors was examined 
by Binary Logistic Regression analysis and 
given in Table 5. When the risk factors for 
PCOS were evaluated in the presence of 
heterozygous genotypes of the genes, it was 
found that GPX1 CT was significant (p = 
0,038), and SOD2 TC, eNOS GT and CAT AT 
genotypes were not significant. (p = 0,301, p = 
0,403 and p = 0,733). TG, FSH and DHEAS 
are significant risk factors. (p = 0,001, p = 
0,007 and p = 0,013). Evaluation of CT 
genotype of GPX1 by PCOS risk factors is 
given in Table 6. The GPX1 heterozygous 
genotype was found to be significant when 
assessed by PCOS risk factors and 
heterozygous genotypes of other genes. In 
addition, when GPX1 CT genotype was 
analyzed together with PCOS risk factors, TG, 
FSH and DHEAS were significantly found in 
the presence of GPX1 heterozygous genotype 
(p = 0,001, p = 0,005 and p = 0,014). 
 
Table 5. Evaluation of PCOS risk factors in the 
presence of heterozygous genotype in the 
genes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assessment of PCOS risk factors with mutant 
alleles is given in Table 7. The analysis PCOS 
risk factors, which is significant with the 
disease-associated mutant alleles, was found to 
be significant among the mutant allele groups 
in the eNOS gene (p = 0,007). 
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Table 6. Significance of PCOS risk factors in 
the presence of the GPX1 heterozygous 
genotype. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The combined analyzes of the homozygous 
mutant and heterozygous genotypes of the 
genes were evaluated by the chi-square test and 
are given in Table 8. The combination of 
SOD2 TT homozygous mutation with GPX1 
TT, eNOS TT and CAT TT homozygous 
mutations did not show any significance for 
PCOS in the patient and control group (p = 
0,346, p = 0,577 and p = 1,000). In addition, 
the association of genotype GPX1 TT 
homozygous mutation with eNOS TT and 
CAT TT homozygote mutation genotype was 
found to be significant for PCOS among the 
groups (p <0,001, p <0,001). In addition, the 
combination of the eNOS TT homozygous 
mutation with the CAT TT genotype was 
found to be significant (p <0,001). When the 
combined analysis of SOD2 gene and CAT 
gene was performed, it was found that there 
was a significant difference between SOD2 
heterozygous genotype carriers and CAT wild 
type genotype carriers. The proportion of 
patients with SOD2 heterozygote genotype 
carriers and CAT wild type genotypes was 
found to be more significant (p = 0,048). When 
combined with GPX1 and eNOS genotypes, 
GPX1 mutant genotype carriers and eNOS 
mutant genotype carriers showed a significant 
difference in disease-related groups (p = 
0,001). In addition, it can be said that the risk 
of disease may be low even with the GPX1 
heterozygote genotype and eNOS wild type 
genotype. 
 
Table 7. Evaluation of PCOS risk factors in 
mutant allele existence.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GPX1 heterozygous genotype carriers and 
CAT wild genotype carriers were found to be 
significant in terms of protection against 
disease when combined genetic analysis of 
GPX1 and CAT gene genotypes were 
                                                        Arslan et al.  Exp Biomed Res 2019; 2(1):8-19 
   
 
14 
 
performed (p = 0,001). GPX1 heterozygote 
genotype and CAT wild type genotype 
association; It is found in 10% in control group 
and 1% in patient group. 
 
Tablo 8. Evaluation of combined analyzes of 
homozygous mutation genotypes and 
heterozygous genotypes of genes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The significance of the combinations of 
heterozygous genotypes in the genes between 
the groups in terms of PCOS was evaluated by 
chi-square test. The combination of the SOD2 
TT homozygous mutation with the GPX1 TT, 
eNOS TT and CAT TT homozygous mutations 
did not appear to be meaningful in terms of 
PCOS in the patient and control group. There 
was no statistically significant difference (p = 
0,315, p = 0,440, p = 1,000) as a result of the 
combination of SOD2 heterozygous genotype 
with GPX1, eNOS and CAT heterozygote 
genotype. The combination of the GPX1 CT 
heterozygous genotype with the eNOS GT 
genotype and the CAT AT genotype did not 
yield any conclusive results (p=0,063, p= 
0,083). In addition, there was no significant 
result in the co-transformation of eNOS GT 
heterozygote genotype and CAT AT 
heterozygote genotype (p = 0,050). 
 
Discussion 
It is known that weight-obesity is an important 
risk factor when assessed in terms of general 
demographic characteristics of control and 
patient groups, and that about 50% of cases 
with PCOS are obese and thus more central 
and android type [15]. Our study supports this 
and statistically significant results have been 
found in terms of obesity and weight in our 
patient group. It has been reported that several 
pathological processes such as uric acid, 
oxidative stress and the formation of oxygen 
radicals and inflammation are associated with 
the studies. In a study performed by Havva 
Keskin et al. [16] a very significant result 
found between PCOS and uric acid. In our 
study, we found that the uric acid level was 
statistically higher in the PCOS group than in 
the control group. In our study, HDL level in 
PCOS was found to be lower than control 
group. TG level was higher in PCOS than 
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control group and a meaningful result was 
obtained. Adamska et al. [17] reported that the 
testosterone concentration in the study with 
PCOS was higher than the control group.  In 
this study, dehydroepiandrosterone sulphate 
and testosterone levels were also found to be 
significant among the groups. In addition, the 
amount of free testosterone is increasing. 
Increased free estradiol and free estradiol lead 
to suppression of FSH levels and increased LH 
in women with PCOS [18]. In this study, FSH 
value was found to be lower in patients with 
PCOS compared to the control group and 
statistically significant in the positive 
direction. Based on these data, it can be said 
that FSH hormone is protective against the 
disease in PCOS. In our study, there was no 
significant difference between groups in terms 
of SOD2 Ala / Val polymorphism. However, 
the presence of the SOD2 homozygote 
mutation alone did not pose a risk in PCOS. 
TG, FSH and DHEAS were found to be 
significant in the presence of SOD2 
homozygous mutation genotype. Evaluation of 
the combination of the SOD2 TT homozygous 
mutation with homozygous mutations of 
GPX1, eNOS and CAT genes did not result in 
a significant value. When the SOD2 gene is 
also analyzed with other genes it does not 
make much sense for PCOS. However, when 
we evaluated the mutant allele combination of 
eNOS and T mutant allele in SOD2 gene, 
significant results were obtained in terms of 
PCOS. In addition, when combined analysis of 
SOD2 gene and CAT gene was found, there 
was a significant difference between groups 
carrying SOD2 heterozygote genotype and 
CAT wild type genotype. Glutathione 
peroxidase, an antioxidant, plays an important 
role in many cases such as signal transduction, 
spermiogenesis, regulation of pre-
inflammatory cytokine production, and 
inactivation of inflammatory ROTs [19,20]. 
GPX1 Pro198Leu polymorphism has been 
reported to be an important risk factor for 
cancer formation in studies performed in 
different countries [21-23]. Regression 
analysis of the risk factors in PCOS by 
homozygous mutation of GPX1 and other 
genes showed that the presence of the GPX1 
homozygote mutation genotype (TT) was 
significant and pose a risk to the disease. In 
addition, TG, FSH and DHEAS were found to 
be a risk factor for the concurrent assessment 
of PCOS risk factors in the presence of GPX 
homozygous mutation. However, it was found 
that the measurement of Fasting Blood Sugar, 
insulin and waist circumference was not 
statistically significant. In addition, FSH has 
been shown to be protective against the disease 
in the presence of GPX1 homozygous 
mutation. When GPX1 heterozygous genotype 
and PCOS risk factors were analyzed, TG, 
FSH and DHEAS were found to be significant 
in the presence of GPX1 CT genotype, but the 
measurements of Fasting Blood Sugar, insulin 
and waist circumference were not significant. 
In terms of the combination of homozygous 
mutation genotypes, the association of GPX1 
with NOS and CAT was significantly found in 
PCOS. In addition, the mutant allele 
combination of the GPX1 and eNOS genes was 
found to be significant for PCOS. Also GPX1 
and eNOS were analyzed in combination, 
significant differences were found in the 
groups in terms of disease when GPX1 mutant 
genotype carriers and eNOS mutant genotype 
carriers coexisted. It can be said that the risk of 
disease may be low in GPX heterozygote 
genotype and NOS wild type genotype bearers. 
Catalase enzyme plays a crucial role in defense 
against oxidative stresses that occur in 
pathological conditions such as Diabetes 
Mellitus, neurodegenerative diseases, cancer 
                                                        Arslan et al.  Exp Biomed Res 2019; 2(1):8-19 
   
 
16 
 
and nutritional deficiency [24]. Many 
researchers have investigated catalase 
polymorphisms and breast cancer, cervical 
cancer, prostate cancer, pancreatic cancer and 
colectal cancers and found significant results 
[25-29]. Significant results were obtained in 
terms of Catalase-21A / T gene polymorphism 
between control and patient groups in our 
study. Together with heterozygous genotype 
of catalase homozygous mutation genotype 
and other genes, TG, FSH and DHEAS were 
found to be statistically significant. Besides, 
FSH has a protective effect against disease in 
the presence of CAT homozygous mutation. 
When the allele (T) associated with the disease 
in the catalase gene is evaluated together with 
PCOS risk factors and mutant alleles of other 
genes, the T allele in Catalase gene is found to 
be insignificant by itself. Significant results 
were found in combination with homozygous 
mutation genotype of catalase gene in 
combination with GPX1 and eNOS 
homozygote mutation genotype. 
Nitric oxide and endothelium nitric oxide 
synthase play an important role in endothelial 
function, regulation: of vascular wall tension 
and vasculoprotective properties [30-32]. 
Nitric oxide also has antioxidant properties. Up 
to now, it has been reported that there are too 
many reports describing eNOS polymorphisms 
and possible associations with diseases [33]. 
Glu298Asp polymorphism is the most 
frequently studied variant [34]. The Glu 298 
Asp polymorphism disrupts the primary 
structure of the protein and results in functional 
changes in the enzyme. In our study, there was 
a statistically significant result in terms of 
eNOS Glu298Asp polymorphism between 
patient and control groups. The genotype of the 
eNOS homozygote mutation was also found to 
be significant when the eNOS gene was 
evaluated together with PCOS risk factors and 
homozygous mutations in other genes. 
Furthermore, in the presence of the 
homozygous mutation genotype (TT) of 
eNOS, together with the risk factors for PCOS, 
TG, FSH and DHEAS were statistically 
significant. Statistically significant results 
were found when different genotypes of eNOS 
gene and other genotypes of other genes are 
evaluated together. Besides, significant results 
were found in cases of NOS3 association with 
GPX1 and CAT genes homozygous mutation 
genotypes. Significant results were also found 
in situation of the combination eNOS, SOD2 
and GPX1 mutant alleles. 
 
Conclusion 
When the different genotypes in the genes are 
analyzed in combination, and when the 
different genotypes come together, the activity 
in the disease varies greatly. It will be possible 
to better understand the role of polymorphisms 
in genes encoding antioxidant enzymes in the 
etiopathogenesis of PCOS in future studies 
with a more comprehensive patient and control 
group. 
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